4Andrews W J, Vasquez B, Nagulesparan M, et al. Insulin therapy in obese, non insulin dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal[J]. Diabetes,1984,33(7):634-642.
1Pratley RE, Weyer C. The role of impaired early insulin secretion in the pathogenesis of type Ⅱ diabetes mellitus[J]. Diabetologia, 2001,44 (8) : 929-945.
2Kahn SE. The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus[J]. Am J Med, 2000,108(Suppl 6a) : 2s- 8s,
3Li YB, Xu W, Liao ZH, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of β-cell function. Diabetes Care, 2004, 27: 2597-2602.
4Osel K, Rhinesmith S, Gaillard T, et al. Impaired insulin sensitivity,insulin secretion,and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in prediabetic African Americans. Diabetes Care, 2004,27 : 1439-1446.
5Gerich JE. Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes? Diabetes,2002,51 Suppl 1 :S117-S121.
6Sundell J, Knuuti J. Insulin and myocardial blood flow. Cardiovasc Res, 2003,57:312-319.
7Ilkova H,Glaser B,Tunckale A,et al.Induction of long-tem glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care,1997,20:1353-1356.
8Yki-Jarvinen H. Pathogenesis of non-insulin dependent diabetes mellitus. Lancet,1994,343:91-95.
9Elizabeth D,Robertson RP. Differentiation between glucose-induced desensitization of insulin secretion and beta-cell exhaustion in the HIT-T 15cell line. Diabetes,1998,47:606-611.
10Del Prato S,Marcherri P,Bonadonna RC. Phasic insulin release and metabolic regulation in type 2 diabetes. Diabetes,2002,51(Suppl 1):s109-116.
5Kahn SE. The importance of the beta - cell in the pathogenesis of type2 diabetes mellltus. Am 1 Med 2000;108(Suppl 6a) :2s -8s.
6Ilkova H,Glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment[J]. Diabetes Care, 1997, 20(9) :1353-1355.
7Li Y, Xu W, Liao Z, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function[J]. Diabetes Care, 2004,27(11) :2597-2602.
8Kahn SE, Half her SM, Heise MA, et al. Glycemie durability of rosiglitazone, metformin, or glyburide monotherapy[J].N Engl J Med,2006,355(23) :Z427-Z443.
9Turner RC, Cull CA, Frighi V, et al. Glyeemic control with diet, sulfonylurea,metformin,or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49) [J]. JAMA, 1999, 281( 21) :2005- 2012.
10Derosa G,Maffioli P,DAngelo A,et al.Effects of insulin therapy with continuous subcutaneous insulin infusion (CSⅡ) in diabetic patients:comparison with multi-daily insulin injections therapy (MDI).Endocrine Journal,2009,56:571-578.
